跳至主要内容
临床试验/JPRN-jRCTs031200150
JPRN-jRCTs031200150招募中3 期

Randomized controlled trial of prevention for COVID-19 with Kampo medicines - IMJEDI-P1 Study

amiki Takao0 个研究点目标入组 6,000 人开始时间: 2020年10月14日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
6,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 75age old(—)
性别
All

入选标准

  • 1) Age from 20 to 75 years old (at the time of registration)
  • 2) Asymptomatic and body temperature below 37.0 degrees Celsius (at the time of registration)
  • 3) Capable of eating orally

排除标准

  • 1)Previous upper respiratory inflammation due to viral infection (including suspected COVID-19)
  • 2)Taking immunosuppressants
  • 3)Allergic to any Kampo medicines
  • 4)History of hypokalaemia, severe hypertension, severe liver dysfunction, and interstitial pneumonia
  • 5)Regularly taking other Kampo medicines
  • 6)Pregnant or possibly pregnant
  • 7)Participating in other research
  • 8)Judged to be unsuitable for this study by the doctor in charge

研究者

发起方
amiki Takao

相似试验